Search Results - "Chernov, Mikhail V"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    p53 is a suppressor of inflammatory response in mice by Komarova, Elena A, Krivokrysenko, Vadim, Wang, Kaihua, Neznanov, Nickolay, Chernov, Mikhail V, Komarov, Pavel G, Brennan, Marie-Luise, Golovkina, Tatiana V, Rokhlin, Oskar W, Kuprash, Dmitry V, Nedospasov, Sergei A, Hazen, Stanley L, Feinstein, Elena, Gudkov, Andrei V

    Published in The FASEB journal (01-06-2005)
    “…ABSTRACTChronic inflammation is known to promote cancer, suggesting that negative regulation of inflammation is likely to be tumor suppressive. We found that…”
    Get full text
    Journal Article
  2. 2

    BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system by Kondratov, Roman V, Chernov, Mikhail V, Kondratova, Anna A, Gorbacheva, Victoria Y, Gudkov, Andrei V, Antoch, Marina P

    Published in Genes & development (01-08-2003)
    “…Mammalian CLOCK and BMAL1 are two members of bHLH-PAS-containing family of transcription factors that represent the positive elements of circadian…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Stabilization and Activation of p53 are Regulated Independently by Different Phosphorylation Events by Chernov, Mikhail V., Ramana, Chilakamarti V., Adler, Victor V., Stark, George R.

    “…Treatment of mouse or human cells with the protein kinase C (PKC) inhibitors H7 or bisindolylmaleimide I induced an increase in the lifetime of p53, leading to…”
    Get full text
    Journal Article
  5. 5

    A Chemical Inhibitor of p53 that Protects Mice from the Side Effects of Cancer Therapy by Komarov, Pavel G., Komarova, Elena A., Kondratov, Roman V., Christov-Tselkov, Konstantin, Coon, John S., Chernov, Mikhail V., Gudkov, Andrei V.

    “…Chemotherapy and radiation therapy for cancer often have severe side effects that limit their efficacy. Because these effects are in part determined by…”
    Get full text
    Journal Article
  6. 6

    Selection-Subtraction Approach (SSA): A Universal Genetic Screening Technique That Enables Negative Selection by Singhi, Aatur D., Kondratov, Roman V., Neznanov, Nickolay, Chernov, Mikhail V., Gudkov, Andrei V., Stark, George R.

    “…Screening of expression libraries for bioactive clones that modulate the growth of mammalian cells has been limited largely to positive selections incapable of…”
    Get full text
    Journal Article
  7. 7

    Post-translational regulation of circadian transcriptional CLOCK(NPAS2)/BMAL1 complex by CRYPTOCHROMES by Kondratov, Roman V, Kondratova, Anna A, Lee, Choogon, Gorbacheva, Victoria Y, Chernov, Mikhail V, Antoch, Marina P

    Published in Cell cycle (Georgetown, Tex.) (15-04-2006)
    “…Mammalian CLOCK(NPAS2), BMAL1 and CRYPTOCHROMEs are core components of the circadian oscillatory mechanism. The active CLOCK/BMAL1 or NPAS2/BMAL1 complexes…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Pharmacological modulators of the circadian clock as potential therapeutic drugs by Antoch, Marina P., Chernov, Mikhail V.

    “…Circadian clocks are molecular time-keeping systems that underlie daily fluctuations in multiple physiological and biochemical processes. It is well recognized…”
    Get full text
    Journal Article
  10. 10

    p53 Inhibitor Pifithrin α Can Suppress Heat Shock and Glucocorticoid Signaling Pathways by Komarova, Elena A., Neznanov, Nickolay, Komarov, Pavel G., Chernov, Mikhail V., Wang, Kaihua, Gudkov, Andrei V.

    Published in The Journal of biological chemistry (02-05-2003)
    “…Pifithrin α (PFTα) is a chemical compound isolated for its ability to suppress p53-mediated transactivation. It can protect cells from p53-mediated apoptosis…”
    Get full text
    Journal Article
  11. 11

    Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo by Komarova, Elena A., Chernov, Mikhail V., Franks, Roberta, Wang, Kaihua, Armin, Gabriella, Zelnick, Carolyn R., Chin, Dot M., Bacus, Sarah S., Stark, George R., Gudkov, Andrei V.

    Published in The EMBO journal (17-03-1997)
    “…To analyze the involvement of p53‐dependent transcriptional activation in normal development and in response to DNA damage in vivo, we created transgenic mice…”
    Get full text
    Journal Article
  12. 12

    Regulation of Ubiquitination and Degradation of p53 in Unstressed Cells through C-terminal Phosphorylation by Chernov, M V, Bean, L J, Lerner, N, Stark, G R

    Published in The Journal of biological chemistry (24-08-2001)
    “…Previously, we found that the protein kinase C (PKC) inhibitor H7 stimulates p53 to accumulate in a form incapable of inducing transcription from p53-dependent…”
    Get full text
    Journal Article
  13. 13

    Posttranslational Regulation of Circadian Transcriptional Clock (NPAS2)/BMAL1 Complex by Cryptochromes by Kondratov, Roman V., Kondratova, Anna A., Lee, Choogon, Gorbacheva, Victoria Y., Chernov, Mikhail V., Antoch, Marina P.

    Published in Cell cycle (Georgetown, Tex.) (15-04-2006)
    “…Mammalian CLOCK(NPAS2), BMAL1 and CRYPTOCHROMEs are core components of the circadian oscillatory mechanism. The active CLOCK/BMAL1 or NPAS2/BMAL1 complexes…”
    Get full text
    Journal Article
  14. 14

    p53 Inhibitor Pifithrin α Can Suppress Heat Shock and Glucocorticoid Signaling Pathways by Elena A. Komarova, Nickolay Neznanov, Pavel G. Komarov, Mikhail V. Chernov, Kaihua Wang, Andrei V. Gudkov

    Published in The Journal of biological chemistry (02-05-2003)
    “…Pifithrin α (PFTα) is a chemical compound isolated for its ability to suppress p53-mediated transactivation. It can protect cells from p53-mediated apoptosis…”
    Get full text
    Journal Article
  15. 15

    Pharmacological modulators of the circadian clock as potential therapeutic drugs by Antoch, Marina P, Chernov, Mikhail V

    Published in Mutation research (01-11-2009)
    “…Circadian clocks are molecular time-keeping systems that underlie daily fluctuations in multiple physiological and biochemical processes. It is well recognized…”
    Get more information
    Journal Article
  16. 16

    The candidate tumour suppressor p33 ING1 cooperates with p53 in cell growth control by Gudkov, Andrei V, Garkavtsev, Igor, Grigorian, Irina A, Ossovskaya, Valeria S, Chernov, Mikhail V, Chumakov, Peter M

    Published in Nature (London) (15-01-1998)
    “…The candidate tumour-suppressor gene ING1 has been identified by using the genetic suppressor element (GSE) methodology. ING1 encodes a nuclear protein,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control by Garkavtsev, I, Grigorian, I A, Ossovskaya, V S, Chernov, M V, Chumakov, P M, Gudkov, A V

    Published in Nature (London) (15-01-1998)
    “…The candidate tumour-suppressor gene ING1 has been identified by using the genetic suppressor element (GSE) methodology. ING1 encodes a nuclear protein,…”
    Get full text
    Journal Article
  19. 19

    The candidate tumour suppressor p33 super(ING1) cooperates with p53 in cell growth control by Garkavtsev, I, Grigorian, IA, Ossovskaya, V S, Chernov, M V, Chumakov, P M, Gudkov, A V

    Published in Nature (London) (05-01-1998)
    “…The candidate tumour-suppressor gene ING1 has been identified by using the genetic suppressor element (GSE) methodology. ING1 encodes a nuclear protein, p33…”
    Get full text
    Journal Article